Anavex Life Sciences
AVXL
39 hedge funds and large institutions have $10.6M invested in Anavex Life Sciences in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 5 reducing their positions, and 3 closing their positions.
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
200% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 5
39% more capital invested
Capital invested by funds: $7.63M → $10.6M (+$2.96M)
26% more funds holding
Funds holding: 31 → 39 (+8)
0% less call options, than puts
Call options by funds: $399K | Put options by funds: $400K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.39M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$285K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$253K |
| 4 |
Goldman Sachs
New York
|
+$246K |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$223K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$570K |
| 2 |
Morgan Stanley
New York
|
-$453K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$345K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$98K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$57.2K |
AVXL Hedge Fund Activity: Q1 2016 in Review
39 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q1 2016, worth a combined $10.6M — up 39% from $7.63M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new AVXL positions and 3 closed out — a net gain of 9 holders — while 15 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.39M. The largest seller was Jane Street, cutting an estimated $570K.
- 39 institutional investors held Anavex Life Sciences (AVXL) as of Q1 2016, up from 31 in Q4 2015.
- Funds reported $10.6M of Anavex Life Sciences stock for Q1 2016, up 39% quarter-over-quarter.
- 12 funds opened new Anavex Life Sciences positions in Q1 2016 and 3 closed out, a net change of +9 holders.
- The largest Anavex Life Sciences buyer in Q1 2016 was Vanguard Group, an estimated $2.39M added.
- The largest Anavex Life Sciences seller in Q1 2016 was Jane Street, an estimated $570K sold.
Based on aggregated 13F filings for Q1 2016.